跳至主要内容
临床试验/NCT05775744
NCT05775744已完成不适用

Management of Postpartum Preeclampsia

Rutgers, The State University of New Jersey2 个研究点 分布在 1 个国家目标入组 392 人开始时间: 2023年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
392
试验地点
2
主要终点
Postpartum Emergency Department visits for hypertensive disorders

研究概览

简要总结

The aim of this study is to assess the effect of a lower treatment threshold for antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.

详细描述

The aim of this study is to assess the effect of lower treatment threshold for initiating antihypertensive medication and tighter blood pressure control, using remote blood pressure monitoring, on reducing Emergency Room visits for our postpartum patients with hypertensive disease.

The investigators will study and compare two cohorts of patients. The first is a retrospective cohort, including patients delivered at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center. The second is a prospective cohort that will enroll patients immediately postpartum who are eligible for our treatment protocol.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Chronic hypertension, gestational hypertension, or preeclampsia.
  • •Delivery of a neonate after 20 weeks during their current hospitalization
  • •Able to consent
  • •18 years old or above
  • •English or Spanish speaking
  • •Planning to follow up with a physician associated with Robert Wood Johnson University Hospital or Cooperman Barnabas Medical Center
  • •Ability to follow directions

排除标准

  • •Any medical condition that the providers feel is a contraindication to the MOPP algorithm.
  • •Planning to follow up with an outside institution.
  • •Unwillingness to take blood pressure at home.

研究组 & 干预措施

Prospective interventional arm

Experimental

The prospective cohort will identify patients in the postpartum period of their delivery hospitalization who are at risk of readmission for hypertensive disorders in the initial six weeks postpartum. Those at risk include patients with diagnosed with chronic hypertension or PIH. Chronic hypertension is defined as either taking antihypertensive medications or a blood pressure of greater than or equal to 140/90 mm Hg prior to 20 weeks of gestation. Pregnancy induced hypertension includes gestational hypertension, preeclampsia without severe features, preeclampsia with severe features and Hemolysis, Elevated Liver enzymes and Low Platelets (HELLP). The minimum requirement to be diagnosed with this spectrum of disorders is having two blood pressures of greater than or equal to 140/90 mm Hg during the antepartum, intrapartum or postpartum periods.

干预措施: Tight postpartum blood pressure control (Other)

Retrospective observational arm

No Intervention

The retrospective cohort will include all patients diagnosed with chronic hypertension or pregnancy-induced hypertensive (PIH) disorders at Robert Wood Johnson University Hospital and Cooperman Barnabas Medical Center in the past two years, including those presenting to the Emergency Department or readmitted for hypertensive disorders, during the immediate six weeks postpartum.

结局指标

主要结局

Postpartum Emergency Department visits for hypertensive disorders

时间窗: Six weeks from date of delivery

Any patient that returns to the Emergency Department for hypertensive disorders

次要结局

  • Postpartum readmissions for hypertensive disorders(6 weeks form date of delivery)
  • Number of acute postpartum complications of preeclampsia(6 weeks from date of delivery)
  • Lab abnormalities because of preeclampsia(6 weeks from date of delivery)
  • Blood pressure at the postpartum visit(6 weeks from date of delivery)
  • Breastfeeding rates at 6 weeks postpartum(6 weeks from date of delivery)
  • Compliance with follow up at postpartum visits(6 weeks from date of delivery)
  • Short-term cardiovascular disease(One year from delivery)
  • Socioeconomic factors(One year from delivery)
  • Composite maternal cardiovascular and other morbidity(One year from delivery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deepika Sagaram, MD

Assistant Clinical Professor

Rutgers, The State University of New Jersey

研究点 (2)

Loading locations...

相似试验